UroToday - Erectile Dysfunction (ED)

Home

Erectile Dysfunction (ED)

UroToday's Erectile Dysfunction section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of erectile dysfunction. Also available are conference coverage for all timely erectile dysfunction science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Erectile Dysfunction
UroToday International Journal

Display

results per page

Results 646 - 660 of 795

<< Start < Prev 41 42 43 44 45 46 47 48 49 50 Next > End >>

Pelvic Floor Exercises Useful For Erectile Dysfunction
Wednesday, 28 September 2005
NEW YORK (Reuters Health) - Exercises that focus on strengthening the bulbocavernosus and ischiocavernosus muscles appear to be a useful treatment for erectile dysfunction, according to the findings of a small study.
read more

Palatin Technologies, Inc. Receives $10 Million Payment From King Pharmaceuticals, Inc.
Tuesday, 27 September 2005
CRANBURY, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (Amex: PTN - News) announced today the receipt of $10 million from King Pharmaceuticals, Inc. (NYSE: KG - News) pursuant to their strategic alliance to jointly develop PT-141 for the treatment of male and female sexual dysfunction.
read more

Simultaneous Placement Of Penile Prosthesis With Radical Prostatectomy Outcomes
Thursday, 15 September 2005
BERKELEY, CA (UroToday Inc.) - Erectile dysfunction (ED) is a common side effect of radical prostatectomy (RP). Some men are not good candidates for nerve sparing RP due to tumor characteristics or they already have significant ED.
read more

Use Of Sildenafil Citrate Unlikely To Trigger MI: Study
Thursday, 25 August 2005
NEW YORK (Reuters Health) - Use of sildenafil citrate in men with erectile dysfunction does not increase the short-term risk of acute myocardial infarction, according to a review of clinical trials.
read more

Erectile Dysfunction [ED] Is Frequently A Manifestation Of Underlying Cardiovascular Problems
Monday, 22 August 2005
(HealthDayNews) -- For men, flagging potency can be a red flag that something's not right in the cardiovascular system.
read more

Prostate Cancer In Men Using Testosterone Supplementation Examined
Thursday, 11 August 2005
BERKELEY, CA (UroToday Inc.) - The growth stimulatory effects of testosterone on prostate cancer have been well established.
read more

Cobra And Auxilium Announce Extension Of Agreement To Manufacture AA4500 For Auxilium Pharmaceuticals, Inc.
Thursday, 04 August 2005
KEELE, England and MALVERN, Pa., Aug. 2 /PRNewswire-FirstCall/ -- Cobra Biomanufacturing Plc (AIM: CBF) and Auxilium
read more

King Pharmaceuticals And Palatin Technologies Initiate Phase IIb Clinical Trials Evaluating PT-141 In Patients Suffering From Erectile Dysfunction
Wednesday, 03 August 2005
King Pharmaceuticals and Palatin Technologies, Inc. announced today that they have initiated patient enrollment in two double- blind, placebo-controlled Phase IIb clinical trials of PT-141 in patients with erectile dysfunction (ED).
read more

Auxilium Pharmaceuticals Announces Top-Line Results for Phase II Androgen Replacement Transmucosal Film Proof Of Concept Study
Monday, 01 August 2005
MALVERN, Pa., Aug. 1 /PRNewswire-FirstCall/ -- Auxilium Pharmaceuticals, Inc., (Nasdaq: AUXL), a specialty pharmaceutical company that develops and markets products for urology and sexual health, announced today top-line findings from the Phase II trial for its androgen replacement product candidate.
read more

Study Examines the Treatment of Men Complaining of a Short Penis
Tuesday, 12 July 2005
BERKELEY, CA (UroToday Inc.) - A preoccupation with penile size is a common condition in the male population and is seen across many cultures.
read more

US OKs New Vision Warning For Viagra-Like Drugs
Tuesday, 12 July 2005
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved new labeling to warn men about possible blindness from Pfizer Inc.'s Viagra and other drugs for erectile dysfunction.
read more

BJUI Mini Reviews - Nonsurgical Factors in the Success of Hypospadias Repair
Friday, 01 July 2005
In this review, publications on the nonsurgical aspects of hypospadias repair are reviewed and compared with the practices of surgeons in the UK, as assessed by a questionnaire.
Login to read more...

Men Complaining of Small Penis Often Misinformed About Normal Size
Wednesday, 29 June 2005
NEW YORK (Reuters Health) - Men complaining of a short penis often overestimate the normal size, according to a report in the June issue of Urology. Education and objective methods of penile size evaluation are the best way to remedy this problem.
read more

Pfizer Says No Blindness Risk From Viagra
Tuesday, 28 June 2005
NEW YORK (Reuters) - Pfizer Inc. (NYSE:PFE - news) on Monday said a review of its popular impotence treatment Viagra turned up no evidence of increased risk of blindness among patients taking the erectile dysfunction drug.
read more

ED Drug Amendment Passage Puts Lives At Risk
Monday, 27 June 2005
Lumping thousands of victims of crippling diseases in with those who abuse the system, Congress passed a ban of Medicare and Medicaid reimbursements for erectile dysfunction drugs today.
read more

Focus on Erectile Dysfunction

Focus on Erectile Dysfunction condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Effects of Once-Daily Tadalafil on Erectile Function in Men with Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia

- by Hartmut Porst, MD and Anne M. Wolka, PhD

Erectile Dysfunction Might Be Associated With Chronic Periodontal Disease: Two Ends of the Cardiovascular Spectrum

- by Yehuda Zadik, DMD, MHA

Tadalafil in the Treatment of Erectile Dysfunction

- by Robert M Coward, MD and Culley C Carson III, MD

Alcohol Consumption and Male Erectile Dysfunction: An Unfounded Reputation for Risk?

- by Kew-Kim Chew, MD

Early Endothelial Dysfunction as a Marker of Vasculogenic Erectile Dysfunction in Young Habitual Cannabis Users

- by Antonio Aversa, MD, PhD

Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer

- by Michael Pinkawa, MD

Erectile aid use by men treated for localized prostate cancer

- by Christopher P. Evans, MD, FACS

Simplified Approach for Correction of Congenital Penile Curvature

- by Tarek Salem, MD, et al.

Biochemical and Microanatomical Mechanism of Erectile Dysfunction

- by Arnold Melman, MD

Vasoactive Intestinal Polypeptide/Phentolamine for Intracavernosal Injection in Erectile Dysfunction

Phosphodiesterase Type 5 Inhibitors in the Management of Erectile Dysfunction Secondary to Treatments for Prostate Cancer: Findings from a Cochrane Systematic Review

Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance

- by Christian P. Pavlovich, MD, et al.

Chronology of erectile function in patients with early functional erections following radical prostatectomy
- by John P. Mulhall, MD, et al.

Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men
- by Benson M. Hoffman, MD, et al.

Racial disparities in erectile dysfunction among participants in the California men's health study
- by James F. Smith, MD, MS, et al.

2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this class
- by Alan W. Shindel, MD

Persistent erectile dysfunction following radical prostatectomy: The association between nerve-sparing status and the prevalence and chronology of venous leak
- by John P. Mulhall, MD, et al.

Penile rehabilitation and neuromodulation
- by Fernando Facio, MD and Arthur L. Burnett, MD

Toward a new 'EPOCH': Optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
- by Gerald Brock, MD, et al.

Erectile Function Recovery Rate after Radical Prostatectomy: A Meta-Analysis
- by John P. Mulhall, MD, et al.

Diabetes, Obesity, and Erectile Dysfunction
- by Ronald Tamler MD, PhD

Recovery of Erectile Function After Radical Prostatectomy is Quantitatively Related to the Response to Intraoperative Cavernous Nerve Stimulation
- by Farhang Rabbani, MD

The impact of preoperative erectile dysfunction on survival after radical prostatectomy
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of post radical prostatectomy erectile dysfunction
- Presented by David P. Wood, MD at the VI Maratona Urológica

Advanced Techniques for Nerve Preservation
- Session Highlight by Ricardo Sånchez-Ortiz, MD from the 4th Annual World Robotic Urology Symposium (WRUS)

Premature Ejaculation: Advances in Definition, Pathophysiology and Pharmacology
- Multimedia Lecture presented by Dana A. Ohl, MD at the 33rd Winter Urologic Forum

Penile Trauma, Peyronie’s Disease and Erectile Dysfunction
- Session Highlight by Harris M. Nagler, MD from the AUA NY Section 2008

Gene Therapy in Erectile Dysfunction
- Presented by Arnold Melman, MD at the AUA NY Section 2008

Gene Therapy in Erectile Dysfunction
- Session Highlight by Harris M. Nagler, MD from the AUA NY Section 2008

Gene Therapy in Erectile Dysfunction
- Podcast of the Presentation by Arnold Melman, MD at the AUA NY Section 2008

Assessment and Treatment of Erectile Function
- Session Highlight by Harris M. Nagler, MD from the AUA NY Section 2008

Penile Prostheses for the Treatment of Erectile Dysfunction
- Session Abstract written by Culley C. Carson, MD from the Masters in Urology 2008

Erectile Dysfunction and the Prostate: What are the Connections?
- Presented by Culley C. Carson, MD at the Masters in Urology 2008

Erectile Dysfunction After Plaque Incision and Grafting: Incidence and Predictors
- Session Highlight by Michael J. Metro, MD from the AUA 2008

Adult Stem Cell Therapy for Erectile Dysfunction
- Session Highlight by Christopher P. Evans, MD, FACS from the AUA 2008